Day: June 4, 2021

Resolutions of the Annual General Meeting of Shareholders from 4 June 2021

Resolutions of the Annual General Meeting of Shareholders from 4 June 2021

The annual general meeting of shareholders of AS Trigon Property Development (registry code: 10106774; hereinafter the “Company”) was held on 4 June 2021 in Tallinn, Pärnu mnt 18. The annual general meeting started at 14:00. 2,608,419 votes represented by the shares of the Company, i.e. 57,9770% of all the votes represented by the shares of the Company, participated at the meeting. Therefore, the annual general meeting was competent to pass resolutions regarding the items on the agenda. Resolutions of the annual general meeting:           1.     Approval of the annual report of the Company for the financial year 2020 To approve the annual report of the Company for the financial year 2020, in accordance with which the consolidated balance sheet value of the Company as at 31 December 2020 was 2,497,679 Euros and the net profit for the financial...

Continue reading

Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders

Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders

TORONTO, June 04, 2021 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock as well as commercializing a new proprietary platform targeting the renal replacement therapy market through its wholly-owned subsidiary Dialco Medical Inc. (“Dialco”), today announced the results of its Annual and Special Meeting of shareholders (the “Shareholders”) held on June 3, 2021 (the “Meeting”). The Company is pleased to announce that all resolutions put forward in the Management Information Circular dated April 29, 2021 (the “Circular”) to its Shareholders were approved. Results of the matters voted on at the Meeting are set out below. Election of Directors Spectral’s five director nominees were elected: Nominee Votes For...

Continue reading

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Dynacor Shareholders Vote for All Proposed Resolutions at the Upcoming Annual Meeting of Shareholders

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Dynacor Shareholders Vote for All Proposed Resolutions at the Upcoming Annual Meeting of Shareholders

MONTREAL, June 04, 2021 (GLOBE NEWSWIRE) — Dynacor Gold Mines Inc. (TSX: DNG/OTC: DNGDF) (Dynacor or the Corporation) is pleased to announce that Institutional Shareholder Services Inc. (“ISS”) and Glass Lewis and Co., LLC (‘Glass Lewis”), both leading independent proxy advisory firms that provide voting recommendations to institutional investors, have recommended that the Corporation’s shareholders vote FOR all of the director nominees and meeting resolutions at Dynacor’s annual meeting of shareholders (the “Meeting”) scheduled for June 17, 2021. The Meeting will take place 1, Place Ville Marie, 40th Floor, Montréal, Québec, H3B 4M4 and via live webcast at https://lavery.zoom.us/j/62888814122. The Corporation strongly encourages shareholders to vote by proxy in advance of the Meeting and not to attend in person. Shareholders may...

Continue reading

Banque Profil de Gestion devient ONE swiss bank SA et son Conseil d’administration nomme une nouvelle direction

Banque Profil de Gestion devient ONE swiss bank SA et son Conseil d’administration nomme une nouvelle direction

Communiqué de presse Banque Profil de Gestion devient ONE swiss bank SA et son Conseil d’administration nomme une nouvelle direction Genève, le 4 juin 2021 – Comme attendu, l’Assemblée Générale Extraordinaire de la Banque Profil de Gestion a approuvé la modification de sa raison sociale en ONE swiss bank SA aujourd’hui. Elle a également élu 3 nouveaux administrateurs. Le Conseil d’administration s’est ensuite réuni pour désigner une nouvelle direction composée de 6 personnes. Leur mission consistera à remettre rapidement la banque sur le chemin de la profitabilité. Ces changements font suite à la fusion des deux entités qui a été décidée le 1er juin. Les membres de la nouvelle direction générale sont à l’image de la banque, énergiques, jeunes, ambitieux et dotés d’un fort esprit entrepreneurial. À la tête de cette nouvelle équipe...

Continue reading

CleanSpark Management to Appear in Water Tower Research Fireside Chat

CleanSpark Management to Appear in Water Tower Research Fireside Chat

SALT LAKE CITY, June 04, 2021 (GLOBE NEWSWIRE) — CleanSpark, Inc. (Nasdaq: CLSK) (the “Company” or “CleanSpark”), a diversified software, services, and clean Bitcoin mining company today announced that CEO Zach Bradford and Executive Chairman Matt Schultz will be participating in the Water Tower Research Virtual Conference and Fireside Chat Series on Monday, June 7, 2021, at 1:00 pm ET. Topics covered will include the Company’s recent partnership agreements, shelf registration, small-cap index rebalances and more. The conversation will be moderated by Shawn Severson, Water Tower’s Head of Sustainable Investing. The chat is expected to also discuss CleanSpark’s status as a founding member of “Think Microgrid” as well as new developments in the energy and Bitcoin business units. Investors interested in participating in this event...

Continue reading

UPDATE -- Vincerx Pharma Presents Clinical Data on VIP152, its PTEFb/CDK9 Inhibitor, in Patients with Double-Hit Lymphoma at ASCO 2021

UPDATE — Vincerx Pharma Presents Clinical Data on VIP152, its PTEFb/CDK9 Inhibitor, in Patients with Double-Hit Lymphoma at ASCO 2021

VIP152 shows favorable safety, on-target pharmacodynamics and signs of durable metabolic complete responses in monotherapy setting Phase 1b study in MYC-Driven relapsed/refractory aggressive lymphomas and advanced solid tumors ongoing PALO ALTO, Calif., June 04, 2021 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC) a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced the presentation of safety and efficacy data from the Phase 1 study of VIP152, the Company’s PTEFb/CDK9 inhibitor, in patients with double-hit lymphoma at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting being held virtually from June 4-8, 2021. “The data generated in double-hit lymphoma are compelling, providing early evidence that on-target...

Continue reading

Maisons du Monde’s 2021 General Meeting: All Resolutions Approved

Maisons du Monde’s 2021 General Meeting: All Resolutions Approved

                PRESS RELEASE MAISONS DU MONDE’S 2021 GENERAL MEETING ALL RESOLUTIONS APPROVED Nantes, 4 June 2021 Maisons du Monde (Euronext Paris : MDM, Code ISIN : FR0013153541) announces that its General Meeting of Shareholders met in Paris today behind closed doors, given the current health context. 78.034% of the share capital was represented at the Meeting which was presided by Peter Child, Chairman of the Board of Directors. Shareholders overwhelmingly approved all of the resolutions submitted to a vote, including the annual and consolidated financial statements for fiscal year 2020 and the proposed cash dividend of 0.30 euro cent per share. The ex-dividend date is 05 July 2021, and the payment date is 07 July 2021. Furthermore, the Meeting approved the appointment of Ms. Cécile Cloarec as a director. The General Meeting’s presentation,...

Continue reading

Immune Therapeutics Announces Restructuring Plan

Immune Therapeutics Announces Restructuring Plan

Orlando, Florida , June 04, 2021 (GLOBE NEWSWIRE) — Immune Therapeutics Inc. (OTC-PINK: IMUN) (the “Company”) announced today that the Company has received and signed a non-binding term sheet to enter into an agreement that would provide working capital and wipe out a significant portion of its long-standing Debt. The Company received the term sheet from existing Immune Shareholders to provide the funds necessary to complete the restructuring of Immune. According to the agreement, the investors will lend a minimum of $700,000 and a maximum of $1,500,000 to the Company in exchange for non-convertible promissory notes bearing interest at 5%. In connection with the transactions above, to the extent a noteholder holds any warrants to purchase shares of common stock of Borrower (“Warrants”), Lender shall have the right...

Continue reading

Euronext announces the sale of Oslo Market Solutions

Euronext announces the sale of Oslo Market Solutions

Contacts Media Contact Investor Relations Amsterdam +31 20 721 4133 Brussels +32 2 620 15 50 +33 1 70 48 24 27 Dublin +353 1 617 4249 Lisbon +351 210 600 614   Milan +39 02 72 42 62 12 Oslo +47 22 34 19 15   Paris +33 1 70 48 24 45       Euronext announces the sale of Oslo Market Solutions Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 04 June 2021 – 18.00 CET – Euronext today announced that it has completed the sale of Oslo Market Solutions (“OMS”) to Infront, a leading European provider of financial market solutions. OMS is an online market data, investor relations, portfolio and trading solutions provider in the Nordic region and was acquired in 2019 as part of the acquisition of Oslo Børs VPS. OMS generated c. €3.3 million of revenue in 2020. The sale of OMS was implemented in the context of the conclusion...

Continue reading

Press release Biocartis Group NV: Results of the Extraordinary Shareholders’ Meeting  held on 4 June 2021

Press release Biocartis Group NV: Results of the Extraordinary Shareholders’ Meeting held on 4 June 2021

PRESS RELEASE: REGULATED INFORMATION4 June 2021, 17:40 CEST Results of the Extraordinary Shareholders’ Meeting held on 4 June 2021 Mechelen, Belgium, 4 June 2021 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), held its extraordinary shareholders’ meeting today. The shareholders approved all items on the agenda of the extraordinary shareholders’ meeting. All documents relating to the shareholders’ meeting can be consulted on the website of the Company. —– END —- More information: Renate DegraveHead of Corporate Communications & Investor Relations Biocartise-mail        rdegrave@biocartis.comtel             +32 15 631 729 mobile         +32 471 53 60 64 About Biocartis Biocartis (Euronext Brussels: BCART) is an innovative molecular...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.